Showing results (1-10 of 875) with videos related to
Sort By:
Pageof 88
Current Heart Failure Reports|April 29, 2010
ST2: a novel remodeling biomarker in acute and chronic heart failureRavi V Shah, James L JanuzziClinics in Laboratory Medicine|February 11, 2014
Soluble ST2 and galectin-3 in heart failureRavi V Shah, James L JanuzziEuropean Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|June 2, 2009
Association between troponin T and impaired left ventricular relaxation in patients with acute decompensated heart failure with preserved systolic functionRavi V Shah, Annabel A Chen-Tournoux, Michael H Picard, et al.European Heart Journal|May 31, 2012
Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoeaRavi V Shah, Quynh A Truong, Hanna K Gaggin, et al.European Journal of Heart Failure|June 8, 2010
Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failureRavi V Shah, Annabel A Chen-Tournoux, Michael H Picard, et al.Circulation. Heart Failure|October 8, 2009
Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspneaRavi V Shah, Annabel A Chen-Tournoux, Michael H Picard, et al.Critical Care (London, England)|July 27, 2012
Measurement of multiple biomarkers in advanced stage heart failure patients treated with pulmonary artery catheter guided therapyJodi L Zilinski, Ravi V Shah, Hanna K Gaggin, et al.Archives of Cardiovascular Diseases|February 29, 2012
The role of natriuretic peptide testing in guiding chronic heart failure management: review of available data and recommendations for useJames L JanuzziCleveland Clinic Journal of Medicine|February 16, 2006
Natriuretic peptide testing: a window into the diagnosis and prognosis of heart failureJames L JanuzziJournal of Cardiovascular Translational Research|April 6, 2013
ST2 as a cardiovascular risk biomarker: from the bench to the bedsideJames L JanuzziPageof 88